Oragenics OGEN
Oragenics: annual report for the year ended Dec 31, 2019
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001493152-20-003343
- Document
- 10-K
- Exhibit 4.6
- Warrants or notes
- Exhibit 10.6
- Material contract
- Exhibit 10.15
- Material contract
- Exhibit 10.23
- Material contract
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- MetaVia MTVA public float $3M, Jun 30, 2025
- Inhibitor Therapeutics INTI public float $3M, Jun 30, 2025
- PTC Therapeutics PTCT public float $3M, Jun 30, 2025
- Integrated Biopharma INBP public float $3M, Dec 31, 2025
- Enveric Biosciences ENVB public float $4M, Jun 30, 2025
